Journal of Biological Chemistry · 2004 · 54 citations · 20 references
Life SciencesBiochemistryEndocrinologyCellular MetabolismMetabolic RegulationMetabolismCarbohydrate MetabolismGlycogen MetabolismHepatic MetabolismHepatic PathophysiologyLiver PhysiologyFasting-induced GluconeogenesisGlycogen Metabolism In FastingGlycogen Storage In LiverHepatic GluconeogenesisHepatic Glycogen MetabolismLiver Metabolism During FastingPeroxisome Proliferator-activated ReceptorsTransgenic Mice
Apart from impaired β-oxidation, Pparα-deficient (Pparα–/–) mice suffer from hypoglycemia during prolonged fasting, suggesting alterations in hepatic glucose metabolism. We compared hepatic glucose metabolism in vivo in wild type (WT) and Pparα–/– mice after a short term fast, applying novel isotopic methods. After a 9-h fast, mice were infused with [U-13C]glucose, [2-13C]glycerol, [1-2H]galactose, and paracetamol for 6 h, and blood and urine was collected in timed intervals. Plasma glucose concentrations remained constant and were not different between the groups. Hepatic glycogen content was 69 ± 11 and 90 ± 31 μmol/g liver after 15 h of fasting in WT and Pparα–/– mice, respectively. The gluconeogenic flux toward glucose 6-phosphate was not different between the groups (i.e. 157 ± 9 and 153 ± 9 μmol/kg/min in WT and Pparα–/– mice, respectively). The gluconeogenic flux toward plasma glucose, however, was decreased in PPARα–/– mice (i.e. 142 ± 9 versus 124 ± 13 μmol/kg/min) (p < 0.05), accounting for the observed decrease (–15%) in hepatic glucose production in Pparα–/– mice. Expression of the gene encoding glucose-6-phosphate hydrolase (G6ph) was lower in the PPARα–/– mice compared with WT mice. In conclusion, Pparα–/– mice were able to maintain a normal total gluconeogenic flux to glucose 6-phosphate during moderate fasting, despite their inability to up-regulate β-oxidation. However, this gluconeogenic flux was directed more toward glycogen, leading to a decreased hepatic glucose output. This was associated with a down-regulation of the expression of G6ph in PPARα-deficient mice. Apart from impaired β-oxidation, Pparα-deficient (Pparα–/–) mice suffer from hypoglycemia during prolonged fasting, suggesting alterations in hepatic glucose metabolism. We compared hepatic glucose metabolism in vivo in wild type (WT) and Pparα–/– mice after a short term fast, applying novel isotopic methods. After a 9-h fast, mice were infused with [U-13C]glucose, [2-13C]glycerol, [1-2H]galactose, and paracetamol for 6 h, and blood and urine was collected in timed intervals. Plasma glucose concentrations remained constant and were not different between the groups. Hepatic glycogen content was 69 ± 11 and 90 ± 31 μmol/g liver after 15 h of fasting in WT and Pparα–/– mice, respectively. The gluconeogenic flux toward glucose 6-phosphate was not different between the groups (i.e. 157 ± 9 and 153 ± 9 μmol/kg/min in WT and Pparα–/– mice, respectively). The gluconeogenic flux toward plasma glucose, however, was decreased in PPARα–/– mice (i.e. 142 ± 9 versus 124 ± 13 μmol/kg/min) (p < 0.05), accounting for the observed decrease (–15%) in hepatic glucose production in Pparα–/– mice. Expression of the gene encoding glucose-6-phosphate hydrolase (G6ph) was lower in the PPARα–/– mice compared with WT mice. In conclusion, Pparα–/– mice were able to maintain a normal total gluconeogenic flux to glucose 6-phosphate during moderate fasting, despite their inability to up-regulate β-oxidation. However, this gluconeogenic flux was directed more toward glycogen, leading to a decreased hepatic glucose output. This was associated with a down-regulation of the expression of G6ph in PPARα-deficient mice. Fuel selection to meet the body's energy demand is of crucial importance during feeding-fasting transitions. The liver plays a central role in this switch. It changes from glucose uptake and glycogen synthesis during feeding to glucose production by gluconeogenesis (GNG) 1The abbreviations used are: GNG, gluconeogenesis; G6P, glucose 6-phosphate; G6PH, glucose-6-phosphate hydrolase (d-glucose-6-phosphate phosphohydrolase; EC 3.1.3.9); G6PT, glucose-6-phosphate translocase; GC-MS, gas chromatography-mass spectrometry; HGP, hepatic glucose production; MIDA, mass isotopomer distribution analysis; PPARα, peroxisome proliferator-activated receptor α; PPARγ, peroxisome proliferator-activated receptor γ; WT, wild type; Par-GlcUA, paracetamol-glucorionide; MOPS, 4-morpholinepropanesulfonic acid. and glycogenolysis during fasting. The origin of hepatic glucose production (HGP) shifts from mainly glycogenolysis to GNG as fasting prolongs. These changes in hepatic glucose metabolism are accompanied by adaptation of hepatic fatty acid metabolism (i.e. from fatty acid synthesis to fatty acid oxidation). This adaptation allows the optimization of fuel substrate utilization. These metabolic changes are, at least in part, effected by the reciprocal action of insulin and glucagon. However, the discovery of nuclear hormone receptors and the (partial) elucidation of their mode of action as ligand-activated regulators of gene expression has considerably complicated the picture. One member of the nuclear hormone receptors is of particular importance in mediating the adaptive response to fasting (i.e. peroxisome proliferator-activated receptor α (PPARα)). PPARα is a fatty acid-activated transcription factor that up-regulates the expression of a variety of genes that encode proteins involved in β-oxidation and lipoprotein metabolism (1Kersten S. Desvergne B. Wahli W. Nature. 2000; 405: 421-424Crossref PubMed Scopus (1665) Google Scholar). Lack of this receptor in Pparα–/– mice results in the inability to up-regulate hepatic fatty acid oxidation and ketogenesis upon fasting in the face of increased concentrations of free fatty acids in the circulation (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google Scholar). It also became apparent that mice lacking PPARα develop hypoglycemia after a prolonged fast (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google Scholar). The etiology of hypoglycemia in fasting Pparα–/– mice is still unclear. It has been hypothesized that it reflects decreased GNG secondary to impaired hepatic fatty acid β-oxidation (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google Scholar). Surprisingly, a recent study suggested increased HGP in long term (24-h) fasted Pparα–/– mice despite the development of hypoglycemia (3Xu J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar). Furthermore, glycogen content of the liver in Pparα–/– mice after a prolonged fast was not reduced in comparison with wild type (WT) mice but, unexpectedly, tended to be higher in the Pparα–/– mice. In contrast, glycogen content of the liver did not increase in Pparα–/– mice upon refeeding, whereas in WT mice, glycogen content strongly increased. These data suggest that the balance between HGP, glycogen synthesis, and GNG at the level of glucose 6-phosphate (G6P) is perturbed in Pparα–/– mice. Partitioning of G6P can be studied in vivo using the glycoconjugate probe technique and mass isotopomer distribution analysis (MIDA) as described by Hellerstein and co-workers (4Hellerstein M.K. Nesse R.A. Letscher A. Linfoot P. Turner S. Metabolism. 1997; 46: 1390-1398Abstract Full Text PDF PubMed Scopus (13) Google Scholar). Recently, we applied these stable isotope techniques to study partitioning of newly synthesized G6P while glucose-6-phosphatase activity was partially inhibited in 24-h fasted rats (5Van Dijk T.H. van der sluijs F.H. Wiegman C.H. Baller J.F. Gustafson L.A. Burger H.J. Herling A.W. Kuipers F. Meijer A.J. Reijngoud D.J. J. Biol. Chem. 2001; 276: 25727-25735Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar). We were able to show that when HGP was diminished by partial inhibition of glucose-6-phosphatase activity, quite surprisingly, de novo synthesis of G6P was unaffected. It appeared that newly synthesized G6P was repartitioned away from plasma glucose to glycogen synthesis, and, as a consequence, the glycogen content of livers of treated rats increased severalfold. The importance of these observations, substantiating data from other groups (6Aiston S. Trinh K.Y. Lange A.J. Newgard C.B. Agius L. J. Biol. Chem. 1999; 274: 24559-24566Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar), is that partitioning of G6P independent of its de novo synthesis represents an additional mechanism of regulation of hepatic glucose production. We now have miniaturized these methods for application in mice (7Van Dijk T.H. Boer T.S. Havinga R. Stellaard F. Kuipers F. Reijngoud D.J. Anal. Biochem. 2003; 322: 1-13Crossref PubMed Scopus (55) Google Scholar). In the present study, we addressed the following questions. 1) Is there a role of PPARα in the control of de novo synthesis of G6P? 2) What are the effects of PPARα deficiency partitioning of newly synthesized G6P during We these in short term fasted Pparα–/– mice by of [U-13C]glucose, [2-13C]glycerol, and blood and urine and the mass isotopomer distribution in glucose and The were compared with expression of genes encoding involved in hepatic glucose metabolism and fatty acid to of PPARα changes in gene Pparα–/– mice and WT mice a were in a a were by the for of the were with a that was to the with F. Havinga R. Full Text PDF PubMed Google Scholar). were to from for at least adaptive response to fasting in Pparα–/– and WT mice was compared were fasted to h, and blood were at and h by and livers were at and h for analysis and Hepatic in vivo metabolism was to the described by Dijk (7Van Dijk T.H. Boer T.S. Havinga R. Stellaard F. Kuipers F. Reijngoud D.J. Anal. Biochem. 2003; 322: 1-13Crossref PubMed Scopus (55) Google Scholar). the of the mice were in metabolic was the of the to urine was 9 h the of the was ± for WT mice and ± for Pparα–/– mice at the of the an at a of during 6 h of a of and paracetamol glucose during the was using and by for gas chromatography-mass were collected the of the and 6 h after the of the The the of the was at intervals. blood was by at the of the and the liver was and in for analysis and and was by liver was and were using a J. Biochem. PubMed Scopus Google Scholar). Plasma free fatty and liver content were using and concentrations were by by S. Anal. Chem. Scopus Google S. Anal. Chem. Scopus Google a acid concentrations were by using as an were to their by of and of to of plasma and the at for were a Plasma insulin were by hepatic content was to J. Biol. Chem. Full Text PDF PubMed Google Scholar). Hepatic glycogen content was in liver after in by The was for at 90 and to by the of acid. was by was to glucose by the with by of glucose at with and G6P of Scholar). for the of G6P were treated by in a and and was to by the of of a of and G6P was with and G6P of Scholar). Hepatic were using a Hepatic was from liver using the was to with to the using of the genes of were by using the of to of total was using the to the using the and and a probe were of as used in the The data were using the expression were the of the results were to The of the and used in this study are in of and acid in a of by for of glucose and from and urine of the and of were to Dijk (5Van Dijk T.H. van der sluijs F.H. Wiegman C.H. Baller J.F. Gustafson L.A. Burger H.J. Herling A.W. Kuipers F. Meijer A.J. Reijngoud D.J. J. Biol. Chem. 2001; 276: 25727-25735Abstract Full Text Full Text PDF PubMed Scopus (78) Google Dijk T.H. Boer T.S. Havinga R. Stellaard F. Kuipers F. Reijngoud D.J. Anal. Biochem. 2003; 322: 1-13Crossref PubMed Scopus (55) Google Scholar). In glucose was by a of a with After the a of glucose was to its and The were in of for was from with and by a The a The with a of in and in The the was a of and to its to acid by in acid and to its After of the a of the were in of for were by an The of mass isotopomer was of glucose glucose and acid were by with for glucose were for glucose were and for acid were to the mass for were by The were to the mass of were of control and a from a of the at the of an of was for when were as described by Dijk (7Van Dijk T.H. Boer T.S. Havinga R. Stellaard F. Kuipers F. Reijngoud D.J. Anal. Biochem. 2003; 322: 1-13Crossref PubMed Scopus (55) Google Scholar). for the of of the of and to total in control be for and for and for the of and to total in be the of constant response of the as from the of the of and to total of the isotopomer distribution by was for the distribution to of This was by as described by Lee J. Biol. PubMed Scopus Google to the distribution of mass to of infused (i.e. [2-13C]glycerol, [U-13C]glucose, and This distribution was used in of isotope and to Hellerstein M.K. R.A. Linfoot P. Turner S. Letscher A. J. Clin. Invest. 1997; PubMed Scopus Google as described by Dijk (5Van Dijk T.H. van der sluijs F.H. Wiegman C.H. Baller J.F. Gustafson L.A. Burger H.J. Herling A.W. Kuipers F. Meijer A.J. Reijngoud D.J. J. Biol. Chem. 2001; 276: 25727-25735Abstract Full Text Full Text PDF PubMed Scopus (78) Google Scholar). of of glucose plasma was by isotope as 1) in represents the of infused [U-13C]glucose, is the of plasma [U-13C]glucose, and is the of The total of of was to the 2) in is the of infused [1-2H]galactose, is the of hepatic as in Par-GlcUA, and is the of was with the of a constant and of infused the hepatic Furthermore, it was that the isotopomer distribution observed in reflects the isotopomer distribution in hepatic of plasma glucose and were as and gluconeogenic to plasma glucose and hepatic were using of glucose and as described in M.K. R.A. J. Google and R.A. J.M. Turner S. Letscher A. Hellerstein M.K. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The gluconeogenic flux plasma glucose and hepatic were as and The total gluconeogenic flux is the of for and in and are the of and plasma glucose, during an of in and are the of plasma glucose and during an of are ± for and activity was using the for for was using analysis of were at < The of to the effects of fasting are in Pparα–/– and WT mice of tended to be lower at 15 h of fasting became lower after h of fasting in Pparα–/– mice compared with WT mice. were observed between WT and Pparα–/– mice with to plasma concentrations decreased to a in groups of mice. after h fasting were ± and ± in WT and Pparα–/– mice, respectively. fatty acid concentrations were higher at 15 h of fasting in Pparα–/– mice and remained to h of fasting. In contrast, the fasting response was diminished in Pparα–/– mice. After an in the of in groups of mice, the increased in WT not in Pparα–/– mice. The changes in plasma did not between Pparα–/– WT mice. After h of fasting, a decrease in was observed in groups of mice. concentrations were ± in WT mice and ± (p < in the Pparα–/– mice at the of the fasting glucose, free fatty and concentrations in WT and PPARα–/– mice, fasted for 15 and fatty ± ± ± ± ± ± ± ± 15 ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± ± in a In the changes in hepatic glycogen and in Pparα–/– and WT mice upon fasting. was not different between groups (i.e. ± and ± in WT and Pparα–/– mice, respectively). hepatic glycogen content was lower in Pparα–/– mice in WT mice. fasting, glycogen decreased more strongly in WT in mice. After 15 h of fasting, hepatic glycogen content in Pparα–/– mice was 90 ± μmol/g compared with 69 ± μmol/g liver in WT mice. This in response of the hepatic glycogen content was apparent also after h of fasting (i.e. 9 ± 9 μmol/g liver in WT mice and ± μmol/g liver in Pparα–/– Hepatic G6P after 15 h of fasting, were not different (i.e. ± and ± μmol/g liver in the WT and Pparα–/– mice, respectively). fasting, hepatic content increased in of mice. However, in Pparα–/– mice, the increase in hepatic content was more in WT mice. Hepatic in the are of plasma glucose and glucose production during the h of the The of the to 15 h of fasting. were fasted for 9 h the Plasma insulin concentrations between groups at the of the (i.e. ± in WT mice and ± in Pparα–/– These were not different from after h of fasting (i.e. ± and ± in WT and Pparα–/– mice, respectively). is from plasma glucose concentrations remained constant and the were in groups of was ± and ± in WT and Pparα–/– mice, respectively. the h of the a constant glucose production be The data show a decreased glucose production in Pparα–/– mice ± 13 in comparison with WT mice ± 11 < In the of de novo synthesis of G6P plasma glucose and the total de novo synthesis of G6P are during the h of the novo synthesis of G6P plasma glucose was constant during the In Pparα–/– mice, the of GNG toward plasma glucose was diminished compared with WT mice (i.e. 124 ± 13 versus 142 ± 9 (p < 0.05), respectively). different was with to the of of newly synthesized G6P the In the of the a was observed in the of of newly In Pparα–/– mice, the from ± at h to ± at 6 h after the of the (p < 0.05), was in WT mice, in it from ± 11 at h to ± at 6 h after the of the (p < the of the the of of newly in Pparα–/– mice was higher in WT mice. the total of de novo synthesis of G6P remained constant during the of the and was not different between the groups (i.e. 153 ± 9 and 157 ± 9 in Pparα–/– and WT mice, respectively). In the partitioning of newly synthesized G6P plasma glucose and is at 6 h after the of the is from this there was a of newly synthesized G6P to in Pparα–/– mice in WT mice. the of the the of newly G6P to synthesis was ± in Pparα–/– mice and ± in WT mice, a increase of in Pparα–/– mice as compared with WT mice. Hepatic Expression expression of genes involved in glucose and metabolism in and and 24-h fasted mice are in The response was observed in expression of genes involved in hepatic glucose and fatty acid oxidation during fasting in WT mice. Expression of and increased upon fasting. expression was increased after the fast compared with the in groups in the Pparα–/– in WT mice after a 24-h the of G6ph and were at 15 h of fasting in Pparα–/– mice compared with WT mice. Hepatic expression of the other genes involved in glucose metabolism (i.e. and the transcription factor were not different in Pparα–/– mice when compared with WT mice after 15 h of fasting. Expression of genes involved in fatty acid oxidation were Expression of did not between Pparα–/– and WT mice at 15 h of fasting, expression of and of was decreased in Pparα–/– mice when compared with WT mice. The hepatic expression of the gene was increased in Pparα–/– mice in comparison with WT mice. after a 24-h fast, expression of genes studied was decreased compared with the and more in mice. This the of this of 24-h fasting be and to a energy in livers of these to we hepatic Hepatic a not to a decrease after h of fasting in the Pparα–/– mice compared with WT mice (i.e. ± versus ± of of In the present study, we addressed the role of PPARα in the control of hepatic glucose metabolism (i.e. de novo synthesis of G6P and its The results show that after a short term fast of 15 h, de novo synthesis of G6P was not by PPARα However, newly synthesized G6P was away from plasma glucose to glycogen Furthermore, deficiency of PPARα in a reduced hepatic expression of and, to a The of the isotope with the application of and the has been in still J. 1999; 277: Google Scholar). We have the application of in mice in a study (7Van Dijk T.H. Boer T.S. Havinga R. Stellaard F. Kuipers F. Reijngoud D.J. Anal. Biochem. 2003; 322: 1-13Crossref PubMed Scopus (55) Google Scholar). In that study, we observed in and hepatic glucose metabolism in 24-h fasted mice not in 9-h fasted mice during the of a of stable The alterations in the adaptive response to fasting of Pparα–/– mice that we observed were in with by other (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar). The hypoglycemia in Pparα–/– mice did not to be to an glucose by (i.e. metabolic of glucose was in WT and Pparα–/– with to the of development of hypoglycemia in fasted mice. (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google and (3Xu J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google lower plasma glucose concentrations 15 and h of fasting in Pparα–/– mice compared with WT mice. In blood glucose concentrations decreased to a in WT mice by (2Kersten S. Seydoux J. Peters J.M. Gonzalez F.J. Desvegne B. Wahli W. J. Clin. Invest. 1999; 103: 1489-1498Crossref PubMed Scopus (1362) Google Scholar). can be for this of stable decrease was observed in plasma glucose of Pparα–/– WT mice. This was different from the in mice during the adaptive in plasma insulin concentrations not an were as have been for fasting mice and did not from the observed in 24-h WT and Pparα–/– mice. In the of a decrease in plasma glucose upon prolonged fasting in infused mice have been to the of gluconeogenic by the of stable The of were that of at of the infused have been for GNG to plasma glucose, however, of the of glucose GNG can be for by the Furthermore, J. 1999; 277: Google that of this of did not increase glucose production in fasted mice. however, of short term of of 6 h as in and were in blood glucose concentrations were the other (3Xu J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google from their that in Pparα–/– mice appeared to be the gluconeogenic substrate at the of results that de novo synthesis of G6P a toward the of gluconeogenic PPARα deficiency in a lower of of glucose observed in WT mice. GNG have been its to plasma glucose results have to that total gluconeogenic flux was inhibited in with inhibition of glucose production. plasma glucose and however, we were able to show that the decrease in hepatic glucose production was not associated with a decrease in the of de novo synthesis of G6P with a more partitioning of newly synthesized G6P In with this glycogen content of liver of Pparα–/– mice remained higher during fasting when compared with WT mice. The metabolic of newly synthesized G6P, to be for the of its de novo of inhibition of de novo synthesis of G6P by its has been by (5Van Dijk T.H. van der sluijs F.H. Wiegman C.H. Baller J.F. Gustafson L.A. Burger H.J. Herling A.W. Kuipers F. Meijer A.J. Reijngoud D.J. J. Biol. Chem. 2001; 276: 25727-25735Abstract Full Text Full Text PDF PubMed Scopus (78) Google as as by (6Aiston S. Trinh K.Y. Lange A.J. Newgard C.B. Agius L. J. Biol. Chem. 1999; 274: 24559-24566Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar). In to (3Xu J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google an increase in glucose production in Pparα–/– mice. However, did not study partitioning of newly synthesized It is not the increase in glucose production in an increased of de novo synthesis of G6P in an partitioning of newly synthesized is that these their in Pparα–/– mice to a whereas we studied Pparα–/– mice to a study mechanism by of of fatty acid oxidation It is that inhibition of β-oxidation GNG by diminished of energy However, data that β-oxidation different effects GNG, the substrate livers of fasted were with as gluconeogenic inhibition of fatty acid oxidation by did not GNG from these H.J. J. Biochem. PubMed Scopus Google Scholar). when and were used as did inhibition of fatty acid oxidation at in inhibition of mechanism have been in the of (3Xu J. Xiao G. Trujillo C. Chang V. Blanco L. Joseph S.B. Bassilian S. Saad M.F. Tontonoz P. Lee P.W.N. Kurland I.J. J. Biol. Chem. 2002; 277: 50237-50244Abstract Full Text Full Text PDF PubMed Scopus (123) Google substrate selection for gluconeogenesis in Pparα–/– mice. The data in this study show in of β-oxidation of fatty acids can partitioning of newly synthesized G6P between plasma glucose and glycogen the of de novo synthesis of by (5Van Dijk T.H. van der sluijs F.H. Wiegman C.H. Baller J.F. Gustafson L.A. Burger H.J. Herling A.W. Kuipers F. Meijer A.J. Reijngoud D.J. J. Biol. Chem. 2001; 276: 25727-25735Abstract Full Text Full Text PDF PubMed Scopus (78) Google and (6Aiston S. Trinh K.Y. Lange A.J. Newgard C.B. Agius L. J. Biol. Chem. 1999; 274: 24559-24566Abstract Full Text Full Text PDF PubMed Scopus (63) Google Scholar), the response of the to maintain of G6P be central in this to PPARα deficiency the partitioning of newly synthesized G6P to The of the G6ph gene were whereas expression of the gene was in the mice. expression of was not in short term fasted Pparα–/– mice. This that reduced G6ph gene expression be a by PPARα glucose production. In the of have been The effects of PPARα be in of long for be of In the G6ph a has been that J. Biochem. J. 2003; PubMed Scopus Google Scholar). Furthermore, of fatty to its activity and the expression of the G6ph gene F. A. S. G. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). We however, that expression of the genes involved in glycogen metabolism (i.e. and were also whereas glycogen metabolism by isotopic appeared to be In conclusion, PPARα deficiency results in partitioning of newly synthesized G6P away from plasma glucose, in a decreased glucose production during short term fasting. expression of G6ph have been a mechanism by this of PPARα deficiency is We de and for and for
20